Gabriel Martínez-Gálvez

Gabriel Martínez-Gálvez

Auto-generated profile, based on publicly available information

Gabriel Martínez-Gálvez

Department of Physiology and Biomedical Engineering, Mayo Clinic , Rochester, Minnesota

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2018 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
HAHirotaka Ata
Hirotaka Ata
TEThomas L Ekstrom
Thomas L Ekstrom
GMGabriel Martínez-Gálvez
Gabriel Martínez-Gálvez
CMCarla M Mann
Carla M Mann
ADAlexey V Dvornikov
Alexey V Dvornikov
SEStephen C. Ekker
Stephen C. Ekker
One key problem in precision genome editing is the unpredictable plurality of sequence outcomes at the site of targeted DNA double stranded breaks (DSBs). This is due to the typical activation of the versatile Non-homologous End Joining (NHEJ) pathway. Such unpredictability limits the utility of somatic gene editing for applications including gene therapy and functional genomics. For germline editing work, the accurate reproduction of the identical alleles using NHEJ is a labor intensive process. In this study, we propose Microhomology-mediated End Joining (MMEJ) as a viable solution for improving somatic sequence homogeneity in vivo, capable of generating a single predictable allele at high rates (56% ~ 86% of the entire mutant allele pool). Using a combined dataset from zebrafish (Danio rerio) in vivo and human HeLa cell in vitro, we identified specific contextual sequence determinants surrounding genomic DSBs for robust MMEJ pathway activation. We then applied our observation to prospectively design MMEJ-inducing sgRNAs against a variety of proof-of-principle genes and demonstrated high levels of mutant allele homogeneity. MMEJ-based DNA repair at these target loci successfully generated F0 mutant zebrafish embryos and larvae that faithfully recapitulated previously reported, recessive, loss-of-function phenotypes. We also tested the generalizability of our approach in cultured human cells. Finally, we provide a novel algorithm, MENTHU (http://genesculpt.org/menthu/), for improved and facile prediction of candidate MMEJ loci. We believe that this MMEJ-centric approach will have a broader impact on genome engineering and its applications. For example, whereas somatic mosaicism hinders efficient recreation of knockout mutant allele at base pair resolution via the standard NHEJ-based approach, we demonstrate that F0 founders transmitted the identical MMEJ allele of interest at high rates. Most importantly, the ability to directly dictate the reading frame of an endogenous target will have important implications for gene therapy applications in human genetic diseases. New gene editing tools precisely break DNA at pre-defined genomic locations, but cells repair these lesions using diverse pathways that often lead to unpredictable outcomes in the resulting DNA sequences. This sequence diversity in gene editing outcomes represents an important obstacle to the application of this technology for human therapies. Using a vertebrate animal as a model system, we provide strong evidence that we can overcome this obstacle by selectively directing DNA repair of double-stranded breaks through a lesser-described pathway termed Microhomology-mediated End Joining (MMEJ). Unlike other, better-understood pathways, MMEJ uses recurring short sequence patterns surrounding the site of DNA breakage. This enables the prediction of repair outcomes with improved accuracy. Importantly, we also show that preferential activation of MMEJ is compatible with effective gene editing. Finally, we provide a simple algorithm and software for designing DNA-breaking reagents that have high chance of activating the MMEJ pathway. We believe that the MMEJ-centric approach to be broadly applicable for a variety of gene editing applications both within the laboratory and for human therapies.

8 August 2018 in Nature Reviews Nephrology
Verified
Journal Article
Closed access
PDF file
ZWZachary WareJoncas
Zachary WareJoncas
JCJarryd M. Campbell
Jarryd M. Campbell
GMGabriel Martínez-Gálvez
Gabriel Martínez-Gálvez
WGWilliam A. C. Gendron
William A. C. Gendron
MBMichael Barry
Michael Barry
SEStephen C. Ekker
Stephen C. Ekker

1 February 2016 in Experimental Neurology
Verified
Journal Article
Closed access
GMGabriel Martínez-Gálvez
Gabriel Martínez-Gálvez
JZJuan M. Zambrano
Juan M. Zambrano
JSJuan C. Diaz Soto
Juan C. Diaz Soto
WZWen-Zhi Zhan
Wen-Zhi Zhan
HGHeather Marie Gransee
Heather Marie Gransee
CMCarlos B. Mantilla
Carlos B. Mantilla

6 February 2016 in Human Gene Therapy
Verified
Journal Article
Open access
AMAlvin C. Ma
Alvin C. Ma
MMMelissa S. McNulty
Melissa S. McNulty
TPTanya L. Poshusta
Tanya L. Poshusta
JCJarryd M. Campbell
Jarryd M. Campbell
GMGabriel Martínez-Gálvez
Gabriel Martínez-Gálvez
SEStephen C. Ekker
Stephen C. Ekker
Transcription activator-like effectors (TALEs) are extremely effective, single-molecule DNA-targeting molecular cursors used for locus-specific genome science applications, including high-precision molecular medicine and other genome engineering applications. TALEs are used in genome engineering for locus-specific DNA editing and imaging, as artificial transcriptional activators and repressors, and for targeted epigenetic modification. TALEs as nucleases (TALENs) are effective editing tools and offer high binding specificity and fewer sequence constraints toward the targeted genome than other custom nuclease systems. One bottleneck of broader TALE use is reagent accessibility. For example, one commonly deployed method uses a multitube, 5-day assembly protocol. Here we describe FusX, a streamlined Golden Gate TALE assembly system that (1) is backward compatible with popular TALE backbones, (2) is functionalized as a single-tube 3-day TALE assembly process, (3) requires only commonly used basic molecular biology reagents, and (4) is cost-effective. More than 100 TALEN pairs have been successfully assembled using FusX, and 27 pairs were quantitatively tested in zebrafish, with each showing high somatic and germline activity. Furthermore, this assembly system is flexible and is compatible with standard molecular biology laboratory tools, but can be scaled with automated laboratory support. To demonstrate, we use a highly accessible and commercially available liquid-handling robot to rapidly and accurately assemble TALEs using the FusX TALE toolkit. Together, the FusX system accelerates TALE-based genomic science applications from basic science screening work for functional genomics testing and molecular medicine applications.

1 November 2018 in Methods
Verified
Journal Article
Open access
BSBrandon W. Simone
Brandon W. Simone
GMGabriel Martínez-Gálvez
Gabriel Martínez-Gálvez
ZWZachary WareJoncas
Zachary WareJoncas
SEStephen C. Ekker
Stephen C. Ekker
The rapid growth of the field of gene editing can largely be attributed to the discovery and optimization of designer endonucleases. These include zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regular interspersed short palindromic repeat (CRISPR) systems including Cas9, Cas12a, and structure-guided nucleases. Zebrafish (Danio rerio) have proven to be a powerful model system for genome engineering testing and applications due to their external development, high fecundity, and ease of housing. As the zebrafish gene editing toolkit continues to grow, it is becoming increasingly important to understand when and how to utilize which of these technologies for maximum efficacy in a particular project. While CRISPR-Cas9 has brought broad attention to the field of genome engineering in recent years, designer endonucleases have been utilized in genome engineering for more than two decades. This chapter provides a brief overview of designer endonuclease and other gene editing technologies in zebrafish as well as some of their known functional benefits and limitations depending on specific project goals. Finally, selected prospects for additional gene editing tools are presented, promising additional options for directed genomic programming of this versatile animal model system.

13 April 2020 in Annals of Global Health
Verified
Journal Article
Open access
PDF file
CWChristina M. Webber
Christina M. Webber
GMGabriel Martínez-Gálvez
Gabriel Martínez-Gálvez
MHManuela Lopera Higuita
Manuela Lopera Higuita
EBEphraim I. Ben-Abraham
Ephraim I. Ben-Abraham
BBBrent M. Berry
Brent M. Berry
JWJohn W. Willson
John W. Willson
Engineering technology plays a pivotal role in the delivery of health care in under-resourced countries by providing an infrastructure to improve patient outcomes. However, sustainability of these technologies is difficult in these settings oftentimes due to limited resources or training. The framework presented in this editorial focuses on establishing medical and laboratory equipment sustainability in developing countries and is comprised of four steps: 1) establishing reliable in-country relationships with stakeholders, 2) identifying needs for sustainable solutions locally, 3) exploring potential solutions and assessing their effort-to-impact ratios, and 4) working with strategic partners to implement solutions with clear performance metrics. By focusing on the sustainability of donated equipment instead of the equipment itself, this method presented distinguishes itself from other philanthropic endeavors in the field by seeking to establish preventive maintenance habits that can impact clinical outcomes of a community long term. Application of this methodology is reported in the Original Research Article "A Low-Cost Humidity Control System to Protect Microscopes in a Tropical Climate" by Asp et. al.